"一个瘤注册计划"倡议
Rajesh Nair1, Bhavna Nayal2, Saurabh Beedkar1
1Department of Neurosurgery, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India.
World neurosurgery: X
|July 17, 2023
概括
这项研究分析了印度南部158例儿童脑瘤,发现星细胞瘤是最常见的. 儿科中枢神经系统瘤显示男性占主导地位,并且在生命的第二个十年中更频繁地发生.
科学领域:
- 神经瘤学神经瘤学
- 儿科神经学 儿科神经学
- 流行病学 流行病学
背景情况:
- 关于印度儿科脑瘤的流行病学概况,已有有限的公布数据.
- 这项研究解决了对儿科中枢神经系统 (CNS) 瘤特征的局部化数据的需求.
研究的目的:
- 进行对儿科中枢神经系统瘤组织学谱的回顾性分析.
- 描述2015年至2021年间手术158例儿科中枢神经系统瘤的发生频率和特征.
主要方法:
- 对158名患有原发性脑瘤的儿科患者 (<18岁) 的回顾性分析.
- 基于世界卫生组织 (WHO) 中枢神经系统瘤分类第四版的瘤分类.
主要成果:
- 儿科中枢神经系统瘤占所有进行手术的内瘤的8.5%.
- 星细胞瘤,神经神经元和神经元瘤是最常见的 (45.6%),其次是胚胎瘤 (19.6%) 和瘤 (15.4%).
- 脑上瘤 (58.2%) 比后腔瘤 (34.6%) 或脊柱瘤 (7.6%) 更常见.
结论:
- 儿童中枢神经系统瘤在男孩和生命的第二个十年中更为普遍.
- 星细胞瘤是最常见的儿科大脑瘤,其次是脑髓母细胞瘤和脑瘤.
- 瘤分布与其他印度和西方中心的研究结果一致.
相关概念视频
Tumor Immunotherapy
567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


